Showing 1,921 - 1,940 results of 113,076 for search '(( 12 we decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.78s Refine Results
  1. 1921
  2. 1922
  3. 1923

    P<i><sub>TET</sub></i>-driven OE of 20 genes results in decreased or increased growth rate. A. Impact of OE on the growth rates of 257 OE strains. by Murielle Chauvel (132263)

    Published 2012
    “…Genes in orange correspond to those whose OE decreased growth with a fold equal to 2. Data are mean and SD of 3 experiments. …”
  4. 1924
  5. 1925
  6. 1926

    Table_12_Tramadol’s Inhibitory Effects on Sexual Behavior: Pharmacological Studies in Serotonin Transporter Knockout Rats.PDF by Diana C. Esquivel-Franco (5455082)

    Published 2018
    “…To investigate whether other mechanisms contribute to the inhibitory effects, WAY100,635, a 5-HT<sub>1A</sub> receptor antagonist and naloxone, a μ-opioid receptor antagonist, were tested on sexual behavior together with tramadol. …”
  7. 1927
  8. 1928
  9. 1929

    At E9.5 Actb<sup>−/−</sup> neural crest cells show a significant decrease of cadherin-11 expression. by Davina Tondeleir (426905)

    Published 2014
    “…<p>(A) Quantification of N-cadherin intensities in Actb<sup>+/+</sup> and Actb<sup>−/−</sup> migratory cells adjacent to the neural tube at E8.5 and E9.5 (left graph, Y-axis: relative intensities) and colocalization of N-cadherin with p75 in migratory cells at E8.5 and E9.5 (right graph, Y-axis: colocalization index on a scale from 0 to 1). …”
  10. 1930

    Trend of temperature decrease in thermogradient freezer during the night from 7:00 P.M. to 5:00 A.M. by Alireza Hasanfard (13919335)

    Published 2022
    “…<p>Trend of temperature decrease in thermogradient freezer during the night from 7:00 P.M. to 5:00 A.M.…”
  11. 1931
  12. 1932
  13. 1933

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  14. 1934

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Compared to DOM, Ariadne shows lower signaling potency and efficacy in multiple signaling pathways examined (G<sub>q</sub>, G<sub>11</sub>, and β-arrestin2) coupled to 5-HT<sub>2A</sub> receptors. We confirmed the shift in signaling for an α-propyl analog and provide a molecular docking rationale for the progressive decrease in signaling potency with the growing length of the α-substituent. …”
  15. 1935
  16. 1936
  17. 1937
  18. 1938

    Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

    Published 2025
    “…White ethnicity, higher somatic symptom, pain catastrophizing, and use of medication pre-injury were associated with lower pre-injury EQ-5D-5L summary and EQ-VAS scores. Phase 1 EQ-5D-5L decreases were associated with female sex, no pre-existing body complaints, lack of expectation for a fast recovery, higher ISS, higher injury pain, and neck, spine/back, upper extremity, or lower extremity injuries. …”
  19. 1939
  20. 1940